TELA Bio Seeks Reverse Stock Split to Avoid Nasdaq Delisting
TELA sits 64% above its 52-week low of $0.501.
Summary
TELA Bio is seeking shareholder approval for a reverse stock split (1-for-5 to 1-for-15) to regain compliance with Nasdaq's $1.00 minimum bid price rule before the September 14, 2026 deadline.
Key Events · Corporate Governance and Compliance · TELA
-
Reverse Stock Split Proposed
Board seeks approval to combine shares at a ratio between 1-for-5 and 1-for-15, with the exact ratio to be set by the Board within one year of approval.
-
Nasdaq Delisting Risk
Stock closed at $0.79 on September 1, 2026, below the $1.00 minimum bid requirement. The 180-day compliance period expires September 14, 2026, and the company is ineligible for an extension due to failing the stockholders' equity requirement.
-
Hearing Request Planned
Company plans to request a Nasdaq Hearings Panel hearing to stay delisting and submit a compliance plan, but the plan depends on shareholder approval of the reverse split.
-
Special Meeting Scheduled
Shareholders will vote on October 8, 2026, with a record date of September 8, 2026. The board unanimously recommends voting FOR both proposals.
Analysis · TELA · Industrial Applications And Services
TELA Bio is asking shareholders to approve a reverse stock split of between 1-for-5 and 1-for-15 to lift its share price back above the $1.00 Nasdaq minimum. The stock closed at $0.79 on September 1, 2026, and the company's 180-day compliance window expires September 14, 2026. The company is also ineligible for an additional 180-day extension because it fails the stockholders' equity requirement, so the reverse split is effectively the only path to maintain its Nasdaq listing. Failure to approve would likely push the stock to the OTC market, where liquidity and institutional access would deteriorate sharply. The board plans to request a Nasdaq hearing to stay delisting and submit a compliance plan, but that plan hinges on shareholder approval of this proposal.
How filings like this one have moved
In the 30 days to Sep 10, 2026, 43.8% of the 571 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.55%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, TELA was trading at $0.82 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $36.9M. The 52-week trading range was $0.50 to $1.73. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.